PRP Use in Treatment of Fistula Ano
Use of Platelet Rich Plasma in Treatment of Perianal Fistula
1 other identifier
interventional
100
1 country
1
Brief Summary
In treatment of perianal fistula several methods are described. However, since the Hippocrates basics of surgical treatment has not changed very much. the aim of this study is to evaluate the effectiveness of PRP gel in treatment of perianal fistula.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 20, 2019
CompletedFirst Submitted
Initial submission to the registry
December 2, 2019
CompletedFirst Posted
Study publicly available on registry
December 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedMay 7, 2026
April 1, 2026
5.1 years
December 2, 2019
April 30, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
percentage of the cure rate
closure of the fistula tract will be evaluated by physical examination and magnetic resonance imaging
1 month
Study Arms (1)
PRP gel application
EXPERIMENTALPRP application for perianal fistula
Interventions
platelet rich plasma prepared from the patients' own blood will be applied to the fistula tract
Eligibility Criteria
You may qualify if:
- patients with perianal fistula
- signing the informed consent form
- above the age of 18
You may not qualify if:
- inflammatory bowel disease
- previous radiation therapy
- having connective tissue disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uşak Universitylead
Study Sites (1)
Uşak University
Uşak, 64100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barış Sevinç, M.D.
Uşak University Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
December 2, 2019
First Posted
December 5, 2019
Study Start
November 20, 2019
Primary Completion
January 1, 2025
Study Completion (Estimated)
December 1, 2026
Last Updated
May 7, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share